Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Canadian Premium Sand Inc. Announces Participation in Canada Investment Summit
-
Cyllene Therapeutics Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EG110A in Neurogenic Detrusor Overactivity (NDO)
-
GeNeuro, Inc., an NRx Company (Nasdaq:NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis (ALS)
-
Passport Couriers Engaging in Widespread Deception, According to TINA.org
-
Osisko Gold Announces Formal Construction Decision and Development Update for the Cariboo Gold Project
-
Department of Energy Mandates Centralia Unit 2 Remain Available for Operation for Additional 90 Days
-
Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference
-
AirJoule Technologies Acquires BitSink, Adding Profitable AI & HPC Infrastructure Cooling Business
-
Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas
-
Brazil Potash Reduces Upfront Capex with 28-Year Construction & Backup Power Contract
-
Asimov Announces Cell Line Development Partnership with Sidewinder Therapeutics to Advance 4-Chain Bispecific Antibody for Solid Tumors
-
Cullinan Therapeutics to Host Virtual Analyst and Investor Event Today to Feature Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer
-
Macerich To Present at BofA Securities 2026 Global Real Estate Conference
-
Mavenir Celebrates Four Award-Winning Entries at Light Reading's 2026 Leading Lights Awards
-
INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board
-
Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification
-
Hop Valley Brewing Co. Makes Its Downtown Eugene Comeback with New Pub at 5th Street Public Market
-
Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development
-
VisionWave Files U.S. Non-Provisional Patent Application Describing ARGUS™, a Proposed Space-Enabled, AI-Driven Counter-Drone Defense Architecture
-
Lyell Immunopharma To Participate in the Baird 2026 Global Healthcare Conference
-
Ashland Innovation Day to be held September 17, 2026
-
Soleo Health Expands Atlanta Footprint With Infusion Centers In Woodstock and Fayetteville, Georgia
-
UMH PROPERTIES, INC. WILL ATTEND AND SHOWCASE TWO HOMES AT THE U.S. DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT’S ANNUAL INNOVATIVE HOUSING SHOWCASE
-
Dmitry Shubov Consulting Issues Strategic Market Advisory on Legal Tech AI Pricing Models as Enterprise General Counsels Tighten Diligence
-
PyroGenesis Comments on Recently Announced Tariffs
-
Slate Medicines Appoints Kenneth Koblan, PhD, as Chief Scientific Officer
-
Village Farms Appoints Deepak Anand to Lead Global Government Affairs
-
Coda Octopus Group Reports Fiscal Third Quarter 2026 Financial Results
-
Dataprana Welcomes Land and Power Executives Amid US Data Center Market Expansion
-
Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Act
-
Kimco Realty® Management to Present at the BofA Securities 2026 Global Real Estate Conference
-
Hain Celestial Reports Fiscal Fourth Quarter and Fiscal Year 2026 Financial Results
-
EU Gas Imports Could Reach 98% by 2050 Without New Field Investment
-
Brookfield to Host 2026 Investor Day on September 17
-
Hain Celestial Enters Into Definitive Agreement to Sell International Business
-
Dance drama recreated from China's classic novel staged in NYC
-
Dance drama recreated from China's classic novel staged in NYC
-
Bitdeer AI Secures 65.1MW A202 Facility at Its Existing Johor, Malaysia Campus; Estimated Active AI Cloud Pipeline Surpasses $7 Billion
-
FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara
-
TRX Gold Announces Major Milestone with Addition to the MVIS® Global Junior Gold Miners Index
-
Exhibition of cultural relics from China's Hebei province opens in Belgrade
-
Cespira™, the Joint Venture between Westport and Volvo Group, reveals how HPDI™ 3.0 advances fuel economy and expands OEM options
-
Global eTraining Heads to Autodesk University 2026 to Showcase AI-Powered Digital Adoption at Scale
-
Parsons Operational, Agile, Defense Solutions Ready Now on Department of War’s Digital Marketplaces
-
Exhibition of cultural relics from China's Hebei province opens in Belgrade
-
Perspective Therapeutics Announces Clinical Collaboration and Supply Agreement with Merck to Evaluate [212Pb]PSV359 in Combination with Keytruda® (Pembrolizumab) in FAP-α Positive Solid Tumors
-
TRX Gold Delivers Record Q4 2026; Achieves Top End of Production Guidance
-
OSB GROUP PLC - Holding(s) in Company
